Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 271 - Recent Statistical Advances of Handling Nonproportional Hazards in Study Design and Data Interpretation
Type: Topic Contributed
Date/Time: Tuesday, August 9, 2022 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #323480
Title: Testing and Estimating Treatment Effect in the Presence of Delayed Onset of the Effect for Cancer Immunotherapies
Author(s): Chang Yu* and Xiang Huang and Hui Nian and Philip He
Companies: Vanderbilt University Medical Center and Vanderbilt University Medical Center and Vanderbilt University Medical Center and Daiichi Sankyo
Keywords: immunotherapy; delayed effect; weighted log-rank test; estimand

Cancer vaccine or immunotherapy trials have shown a delayed onset of effect for the experimental therapy, manifested as a delayed separation of the survival curves, thus a violation of the proportional hazards assumption. Recently, significant amount of work has been focused on the power loss incurred by the standard log-rank test, and various alternative tests have been proposed. In this work, we first present an R package that facilitates the sample size and power analysis for a weighted log-rank test that we recently developed to treat the problem, and the methods are extended to existing tests such as those in Fleming-Harrington class. Then we turn our focus to an estimand of the delayed treatment effect. We discuss the maximal likelihood estimator and propose alternative approaches to estimate the delay and the effect.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program